North America미국Healthcare and bioHealthcare and bio2018

Failure archive detail

테라노스 failure case

테라노스 is an archived business failure case from 미국 in Healthcare and bio. It is recorded as ended around 2018. Main failure signals: Regulation, Contracts, PMF failure, Funding dependency.

No comments yet. Leave the first failure-prevention note.

RegulationContractsProduct-market fit failureFunding dependency
Detailed case notes

Business model: 혈액 진단 검사 플랫폼

Failure stage: ended around 2018

Original text is not exposed directly. Use source links and the localized summary for review.

  • 핵심 성능 검증 자료가 독립적으로 확인되지 않음
  • 규제 산업에서 감사 가능성보다 성장 서사가 앞섬
  • 고객 안전과 임상 정확도가 사업 일정에 밀림
영어 · 전체 번역 완료
View translation

테라노스 is an archived business failure case from 미국 in Healthcare and bio. It is recorded as ended around 2018. Main failure signals: Regulation, Contracts, PMF failure, Funding dependency.

What founders can learnFor a 혈액 진단 검사 플랫폼 business, founders should check Regulation, Contracts, PMF failure, Funding dependency before scaling. If signals such as weak demand, poor unit economics, or rising fixed costs appear, recalculate unit economics, retention, fixed costs, and legal exposure before expanding.
Sources and related links
위키백과 원문 링크 1미국 증권거래위원회 자료 링크 2
Back to full archiveOpen primary source